Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7555)
All Articles published online
|
Publishing Process of This Article
|
Jun 18, 2015 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lyra-González I, Flores-Fong LE, González-García I, Medina-Preciado D, Armendáriz-Borunda J. MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine. World J Hepatol 2015; 7(11): 1530-1540 [PMID: 26085912 DOI: 10.4254/wjh.v7.i11.1530] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i11/1530.htm |
| Number | Citing Articles |
| 1 |
Yujing Wu, Shuang Liu, Zhijuan Fan, Yaqiong Tian, Lei Zhang, Shuye Liu. Establishment and Validation of a Blood Test-based Nomogram
to
Diagnose Patients with AFP-negative HCC. Current Cancer Drug Targets 2024; 24(5): 556 doi: 10.2174/0115680096264770231113103930
|
| 2 |
Agnieszka Piechowska, Celina Kruszniewska-Rajs, Magdalena Kimsa-Dudek, Magdalena Kołomańska, Barbara Strzałka-Mrozik, Joanna Gola, Stanisław Głuszek. The role of miR-370 and miR-138 in the regulation of BMP2 suppressor gene expression in colorectal cancer: preliminary studies. Journal of Cancer Research and Clinical Oncology 2022; 148(7): 1569 doi: 10.1007/s00432-022-03977-4
|
| 3 |
Xue-Min Wu, Zhi-Feng Xi, Pinhu Liao, Hong-Dong Huang, Xiao-Ying Huang, Chao Wang, Yun Ma, Qiang Xia, Jin-Guang Yao, Xi-Dai Long. Diagnostic and prognostic potential of serum microRNA-4651 for patients with hepatocellular carcinoma related to aflatoxin B1. Oncotarget 2017; 8(46): 81235 doi: 10.18632/oncotarget.16027
|
| 4 |
Peipei Hao, Fengming Yue, Xian Xian, Qian Ren, Huixian Cui, Yunpeng Wang. Inhibiting effect of MicroRNA-3619-5p/PSMD10 axis on liver cancer cell growth in vivo and in vitro. Life Sciences 2020; 254: 117632 doi: 10.1016/j.lfs.2020.117632
|
| 5 |
Bin Sun, Weidan Ji, Chunying Liu, Xuejing Lin, Lei Chen, Haihua Qian, Changqing Su. miR‐2392 functions as tumour suppressor and inhibits malignant progression of hepatocellular carcinoma via directly targeting JAG2. Liver International 2022; 42(7): 1658 doi: 10.1111/liv.15284
|
| 6 |
Mascha Korsch, Alexander Margetts, Claes Wahlestedt, Ines Lohse. Non-Coding RNAs in Hepatocellular Carcinoma. Livers 2022; 2(3): 185 doi: 10.3390/livers2030017
|
| 7 |
Juan Cristina, Ricardo Recarey. Identification of MicroRNA-Like Molecules Derived from the Antigenome RNA of Hepatitis C Virus: A Bioinformatics Approach. Natural Science 2016; 8(04): 180 doi: 10.4236/ns.2016.84021
|
| 8 |
Peng Li, Qingmin Li, Yanqiang Zhang, Shaojun Sun, Shuntao Liu, Zhaoxi Lu. MiR-422a targets MAPKK6 and regulates cell growth and apoptosis in colorectal cancer cells. Biomedicine & Pharmacotherapy 2018; 104: 832 doi: 10.1016/j.biopha.2018.03.013
|
| 9 |
Guangbin Jiang, Li Wen, Weiping Deng, Zhiyuan Jian, Hongmei Zheng. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2. Biomedicine & Pharmacotherapy 2017; 90: 806 doi: 10.1016/j.biopha.2017.03.081
|
| 10 |
Jaihwan Kim, Ji Kon Ryu, Sang Hyub Lee, Yong-Tae Kim. MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers. Gut and Liver 2016; 10(5): 836 doi: 10.5009/gnl15460
|
| 11 |
Hong-Bin Jiao, Wei Wang, Meng-Nan Guo, Ya-Li Su, De-Quan Pang, Bao-Lin Wang, Jun Shi, Jing-Hua Wu. Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancer. World Journal of Clinical Cases 2022; 10(26): 9264-9275 doi: 10.12998/wjcc.v10.i26.9264
|
| 12 |
HAIFEI HE, WEI TIAN, HAILONG CHEN, YONGCHUAN DENG. MicroRNA-101 sensitizes hepatocellular carcinoma cells to doxorubicin-induced apoptosis via targeting Mcl-1. Molecular Medicine Reports 2016; 13(2): 1923 doi: 10.3892/mmr.2015.4727
|
| 13 |
Ping Luo, Sanyun Wu, Yalan Yu, Xinliang Ming, Shuo Li, Xuelan Zuo, Jiancheng Tu. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage. Pathology & Oncology Research 2020; 26(2): 599 doi: 10.1007/s12253-019-00585-5
|
| 14 |
Li Huang, Zhuning Mo, Zuojian Hu, Linyan Zhang, Shanzi Qin, Xue Qin, Shan Li. Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-1161-y
|
| 15 |
Ke Jin, Tong Li, Gonzalo Sánchez-Duffhues, Fangfang Zhou, Long Zhang. Involvement of inflammation and its related microRNAs in hepatocellular carcinoma. Oncotarget 2017; 8(13): 22145 doi: 10.18632/oncotarget.13530
|
| 16 |
Guangbin Jiang, Li Wen, Hongmei Zheng, Zhiyuan Jian, Weiping Deng. miR‐204‐5p targeting SIRT1 regulates hepatocellular carcinoma progression. Cell Biochemistry and Function 2016; 34(7): 505 doi: 10.1002/cbf.3223
|
| 17 |
Guanyu Zhang, Yiran Li, Jiasheng Xu, Zhenfang Xiong. Advances in the role of miRNAs in the occurrence and development of osteosarcoma. Open Medicine 2020; 15(1): 1003 doi: 10.1515/med-2020-0205
|
| 18 |
Gui-Xi Zheng, Ai-Lin Qu, Yong-Mei Yang, Xin Zhang, Shou-Cai Zhang, Chuan-Xin Wang. miR-422a is an independent prognostic factor and functions as a potential tumor suppressor in colorectal cancer. World Journal of Gastroenterology 2016; 22(24): 5589-5597 doi: 10.3748/wjg.v22.i24.5589
|
| 19 |
Pingping Dong, Xiaoxiao Wang, Longzi Liu, Wenqing Tang, Lijie Ma, Wenjiao Zeng, Shaoyang Sun, Li Zhang, Ningping Zhang, Xizhong Shen, Harry L.A. Janssen, Ling Dong, Si Zhang, She Chen. Dampened VEPH1 activates mTORC1 signaling by weakening the TSC1/TSC2 association in hepatocellular carcinoma. Journal of Hepatology 2020; 73(6): 1446 doi: 10.1016/j.jhep.2020.06.027
|
| 20 |
Xi-Dai Long, Wei-Zhong Tang, Jun Lu, Xiao-Ying Huang, Jin-Guang Yao, Tian-Qi Zhang, Xing-Zhizi Wang, Qun-Ying Su, Chun-Ying Luo, Xue-Ming Wu, Chao Wang, Li-Xia Zeng, Qiang Xia, Yun Ma. Hepatocellular Carcinoma - Advances in Diagnosis and Treatment. 2018; doi: 10.5772/intechopen.72276
|
| 21 |
Kashif Rafiq Zahid, Mingyang Su, Abdur Rehman Raza Khan, Shiming Han, Gou Deming, Umar Raza. Systems biology based meth-miRNA–mRNA regulatory network identifies metabolic imbalance and hyperactive cell cycle signaling involved in hepatocellular carcinoma onset and progression. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0804-3
|
| 22 |
J Huang, J Yang, Y Lei, H Gao, T Wei, L Luo, F Zhang, H Chen, Q Zeng, L Guo. An ANCCA/PRO2000-miR-520a-E2F2 regulatory loop as a driving force for the development of hepatocellular carcinoma. Oncogenesis 2016; 5(5): e229 doi: 10.1038/oncsis.2016.22
|
| 23 |
Daniela Campion, Alessandra Tucci, Paola Ponzo, Gian Paolo Caviglia. Non-invasive biomarkers for the detection of hepatocellular carcinoma. Minerva Biotecnologica 2019; 31(1) doi: 10.23736/S1120-4826.18.02488-6
|
| 24 |
Ming-De Yan, Chih-Jung Yao, Jyh-Ming Chow, Chia-Lun Chang, Pai-An Hwang, Shuang-En Chuang, Jacqueline Whang-Peng, Gi-Ming Lai. Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells. Marine Drugs 2015; 13(10): 6099 doi: 10.3390/md13106099
|
| 25 |
Yanping Wei, Rongquan He, Yuzhuang Wu, Binliang Gan, Peirong Wu, Xiaohui Qiu, Aihua Lan, Gang Chen, Qiuyan Wang, Xinggu Lin, Yingchun Chen, Zengnan Mo. Comprehensive investigation of aberrant microRNA profiling in bladder cancer tissues. Tumor Biology 2016; 37(9): 12555 doi: 10.1007/s13277-016-5121-z
|